RxDoctor Payments Data

Robert Bush

Family Medicine · Columbus, GANPI 1952302481

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $774 and has fallen 87.0% since, to $101 in 2021.

$1,622in general payments, 2019–2025

Across 127 payments — averaging $12.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$354
  • Novo Nordisk$283
  • AbbVie$158
  • Pfizer$133
  • Novartis$119
  • Johnson & Johnson$113
  • plus $462 from 14 others

What the payments were for

  • Food & beverage$1,622100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,622 in reported general payments places this provider in the 65th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia →

Other family medicine in Columbus

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →